Evidence map›Paper›PMID 30569204›Full record

ReviewCancer immunology, immunotherapy : CII2019

MDSCs in infectious diseases: regulation, roles, and readjustment.

Anca Dorhoi, Estibaliz Glaría, Thalia Garcia-Tellez, Natalie E Nieuwenhuizen, Gennadiy Zelinskyy, Benoit Favier, Anurag Singh, Jan Ehrchen, Cornelia Gujer, Christian Münz and 6 more

Abstract readReview
In one paragraph

Review in Cancer immunology, immunotherapy : CII, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Article
  3. Immune cell disorder in viral pneumonia.Journal of translational medicine · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Towards a map of the immune system manipulation network byFrontiers in cellular and infection microbiology · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Anca DorhoiInstitute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Südufer 10, 17493, Greifswald, Insel Riems, Germany. anca.dorhoi@fli.de.
Estibaliz GlaríaNuclear Receptor Group, Department of Cell Biology, Physiology and Immunology, School of Biology, University of Barcelona, Av. Diagonal, 643, 3rd floor, 08028, Barcelona, Spain.ORCID http://orcid.org/0000-0002-5917-9629
Thalia Garcia-TellezInstitut Pasteur, HIV Inflammation and Persistence Unit, Paris, France.ORCID http://orcid.org/0000-0002-1968-3134
Natalie E NieuwenhuizenDepartment of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.ORCID http://orcid.org/0000-0001-5749-2462
Gennadiy ZelinskyyInstitute of Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.ORCID http://orcid.org/0000-0001-6338-2382
Benoit FavierImmunology of Viral Infections and Autoimmune Diseases (IMVA), IDMIT Department, CEA, Université Paris Sud 11, INSERM U1184, IBJF, Fontenay-aux-Roses, France.ORCID http://orcid.org/0000-0001-9191-6273
Anurag SinghUniversity Children's Hospital and Interdisciplinary Center for Infectious Diseases, University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-9370-1038
Jan EhrchenDepartment of Dermatology, University Hospital Münster, Münster, Germany.
Cornelia GujerViral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zurich, Switzerland.
Christian MünzViral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-6419-1940
Margarida Saraivai3S-Instituto de Investigação e Inovação em Saúde, Porto, Portugal.ORCID http://orcid.org/0000-0002-8180-1293
Yahya SohrabiMolecular and Translational Cardiology, Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany.ORCID http://orcid.org/0000-0001-5268-238X
Ana E SousaInstituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.ORCID http://orcid.org/0000-0002-4618-9799
Peter DelputteLaboratory of Microbiology, Parasitology and Hygiene (LMPH), Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium.ORCID http://orcid.org/0000-0003-3972-616X
Michaela Müller-TrutwinInstitut Pasteur, HIV Inflammation and Persistence Unit, Paris, France.ORCID http://orcid.org/0000-0002-3854-2396
Annabel F ValledorNuclear Receptor Group, Department of Cell Biology, Physiology and Immunology, School of Biology, University of Barcelona, Av. Diagonal, 643, 3rd floor, 08028, Barcelona, Spain. afernandezvalledor@ub.edu.ORCID http://orcid.org/0000-0003-4232-2633

Funding

COST (European Cooperation in Science and Technology) COST Action BM1404 Mye-EUNITER (www.mye-euniter.eu)
6 · The paper itself

Abstract

Many pathogens, ranging from viruses to multicellular parasites, promote expansion of MDSCs, which are myeloid cells that exhibit immunosuppressive features. The roles of MDSCs in infection depend on the class and virulence mechanisms of the pathogen, the stage of the disease, and the pathology associated with the infection. This work compiles evidence supported by functional assays on the roles of different subsets of MDSCs in acute and chronic infections, including pathogen-associated malignancies, and discusses strategies to modulate MDSC dynamics to benefit the host.

Indexed as

Acute DiseaseAnimalsBiomarkersChronic DiseaseCommunicable DiseasesDisease SusceptibilityHost-Pathogen InteractionsHumansImmunomodulationMolecular Targeted TherapyMyeloid-Derived Suppressor CellsBiomarkersImmunosuppressionInfectionMDSCMye-EUNITERMyeloid regulatory cellsOncogenic viruses

Identifiers

PMID30569204
PMCPMC11028159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.